A rationally designed peptide enhances homologous recombination in vitro and resistance to DNA damaging agents in vivo

被引:0
|
作者
Chen, Li-Tzu [1 ,2 ]
Wang, Andrew H. -J. [1 ,2 ]
机构
[1] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan
[2] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
关键词
ESCHERICHIA-COLI RECA; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; HELICAL FILAMENTS; COMPLEX-FORMATION; RAD51; PROTEIN; DMC1; REPAIR; STABILIZATION;
D O I
10.1093/nar/gkq182
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RecA family of proteins is essential in homologous recombination, a critical step in DNA repair. Here, we report that a rationally-designed small peptide based on the crystal structure of Escherichia coli RecA-DNA complex can promote homologous recombination through the enhancement of both RecA-mediated strand assimilation and three-strand exchange activity. Among 17 peptides tested, peptide #3 with the amino acid sequence of IRFLTARRR has the most potent activity in promoting the RecA-mediated D-loop formation by similar to 7.2-fold at 37 degrees C. Other peptides such as IRFLTAKKK and IRLLTARRR also have similar, albeit lower, activities. Therefore, hydrophobicity and poly-positive charges, and the space between them in those small peptides are crucial features for such activities. The enhancement of recombination by these peptides appears to be a general phenomenon as similar results were seen by using different plasmids. Remarkably, peptide #3 alone without RecA can also promote the D-loop formation at elevated temperature. Cell viability assays showed that the peptide elevates mammalian cell resistance to two cytotoxic DNA drugs, cisplatin and doxorubicin. The rescue of viability may result from increased DNA repair efficiency. Such peptides may find future biological applications.
引用
收藏
页码:4361 / 4371
页数:11
相关论文
共 50 条
  • [31] A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery
    Iwai, Kenichi
    Nambu, Tadahiro
    Kashima, Yukie
    Yu, Jie
    Eng, Kurt
    Miyamoto, Kazumasa
    Kakoi, Kazuyo
    Gotou, Masamitsu
    Takeuchi, Toshiyuki
    Kogame, Akifumi
    Sappal, Jessica
    Murai, Saomi
    Haeno, Hiroshi
    Kageyama, Shun-Ichiro
    Kurasawa, Osamu
    Niu, Huifeng
    Kannan, Karuppiah
    Ohashi, Akihiro
    SCIENCE ADVANCES, 2021, 7 (21)
  • [32] DNA glycosylase activity and cell proliferation are key factors in modulating homologous recombination in vivo
    Kiraly, Orsolya
    Gong, Guanyu
    Roytman, Megan D.
    Yamada, Yoshiyuki
    Samson, Leona D.
    Engelward, Bevin P.
    CARCINOGENESIS, 2014, 35 (11) : 2495 - 2502
  • [33] In vivo Importance of Homologous Recombination DNA Repair for Mouse Neural Stem and Progenitor Cells
    Rousseau, Laure
    Etienne, Olivier
    Roque, Telma
    Desmaze, Chantal
    Haton, Celine
    Mouthon, Marc-Andre
    Bernardino-Sgherri, Jacqueline
    Essers, Jeroen
    Kanaar, Roland
    Boussin, Francois D.
    PLOS ONE, 2012, 7 (05):
  • [34] Modulation of Gemcitabine Accumulation by DNA-Damaging Agents: Mechanisms and Specificity in an In Vitro Model
    Metharom, Ekkaphon
    Galettis, Peter
    Manners, Susan
    Links, Matthew
    ANTICANCER RESEARCH, 2010, 30 (09) : 3669 - 3673
  • [35] Homologous recombination enhances radioresistance in hypopharyngeal cancer cell line by targeting DNA damage response
    Liu, Chuan
    Liao, Kui
    Gross, Neil
    Wang, Zhihai
    Li, Guojun
    Zuo, Wenqi
    Zhong, Shixun
    Zhang, Zixin
    Zhang, Hua
    Yang, Jianming
    Hu, Guohua
    ORAL ONCOLOGY, 2020, 100
  • [36] SNS-595 has synergistic activity in vitro with DNA damaging agents and antimetabolites
    Wright, Jasmin
    Hyde, Jennifer
    Silverman, Jeffrey A.
    Walker, Duncan H.
    Arkin, Michelle R.
    CANCER RESEARCH, 2006, 66 (08)
  • [37] Novel ATM/ATR pathway inhibitors sensitize p53-deficient cells to DNA-damaging agents in vitro and in vivo
    Kawasumi, M.
    Sloan, H.
    Bradner, J.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S30 - S30
  • [38] Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo
    Byeong-Woo Park
    Hong-Tao Zhang
    Chuanjin Wu
    Alan Berezov
    Xin Zhang
    Raj Dua
    Qiang Wang
    Gary Kao
    Donald M. O'Rourke
    Mark I. Greene
    Ramachandran Murali
    Nature Biotechnology, 2000, 18 : 194 - 198
  • [39] TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agents
    Coulter, Jonathan B.
    Lopez-Bertoni, Hernando
    Kuhns, Katherine J.
    Lee, Richard S.
    Laterra, John
    Bressler, Joseph P.
    EPIGENETICS, 2017, 12 (10) : 854 - 864
  • [40] Rationally designed anti-HER2/neu peptide mimetic disables p185HER2/neu tyrosine kinases in vitro and in vivo
    Park, BW
    Zhang, HT
    Wu, CJ
    Berezov, A
    Zhang, X
    Dua, R
    Wang, Q
    Kao, G
    O'Rourke, DM
    Greene, MI
    Murali, R
    NATURE BIOTECHNOLOGY, 2000, 18 (02) : 194 - 198